Cell-free fetal DNA versus maternal serum screening for trisomy 21 in pregnant women with and without assisted reproduction technology: a prospective interventional study

Purpose Cell-free DNA (cfDNA) as a primary screening test has been available for years but few studies have addressed this option in a prospective manner. The question is of interest after reports that maternal serum screening (MSS) is less accurate for pregnancies resulting from assisted reproducti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Genetics in medicine 2018-11, Vol.20 (11), p.1346-1353
Hauptverfasser:	Costa, Jean-Marc, Letourneau, Alexandra, Favre, Romain, Bidat, Laurent, Belaisch-Allart, Joelle, Jouannic, Jean-Marie, Quarello, Edwin, Senat, Marie-Victoire, Broussin, Bernard, Tsatsaris, Vassilis, Demain, Adèle, Kleinfinger, Pascale, Lohmann, Laurence, Agostini, Hélène, Bouyer, Jean, Benachi, Alexandra
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biomedical and Life Sciences Biomedicine Cell-Free Nucleic Acids - blood Cell-Free Nucleic Acids - genetics Down Syndrome - blood Down Syndrome - genetics Down Syndrome - pathology Female Fetus Genetic Testing Human Genetics Humans Laboratory Medicine Maternal Age Pregnancy Pregnancy Trimester, First Prenatal Diagnosis - methods Reproductive Techniques, Assisted
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!